East Haven, CT, United States of America

Tord Hjalt

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tord Hjalt. Retrieved from https://idiyas.com/inventor/tord-hjalt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 25.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal1 out of 834,659 
Other
 patents

Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tord Hjalt: A Pioneer in Therapeutic Polypeptides

Introduction

Tord Hjalt, an innovative inventor based in East Haven, Connecticut, has made significant contributions to the field of biotechnology through his work on therapeutic polypeptides. With a focus on the biochemical aspects of health, Hjalt's innovations reflect his commitment to enhancing medical treatments and diagnostics.

Latest Patents

Hjalt holds a patent that delves into the realm of therapeutic polypeptides, specifically concerning nucleic acids that encode G-coupled protein-receptor related polypeptides. His patent details the nucleic acid sequences and the corresponding polypeptides, which are essential in developing antibodies that can specifically bind to these proteins. Additionally, the invention encompasses derivatives, variants, mutants, or fragments of the polypeptide and polynucleotide. The significance of this patent lies in its implications for therapeutic, diagnostic, and research methodologies aimed at diagnosing, treating, and preventing various disorders associated with these novel human nucleic acids and proteins.

Career Highlights

Throughout his career, Tord Hjalt has shown remarkable dedication to innovation in the field of biotechnology. His work has not only led to the creation of a pivotal patent but has also contributed to the broader understanding of G-coupled protein receptors, thus highlighting his stature as a valuable inventor in the scientific community.

Collaborations

Hjalt has collaborated with notable colleagues in his efforts, including David W. Anderson and Jason C. Baumgartner. This teamwork has been instrumental in furthering the research and development of the therapeutic applications stemming from his innovations, ultimately enhancing the collective impact in the field.

Conclusion

Tord Hjalt's contributions to biotechnology through his patent on therapeutic polypeptides signify a vital advancement in medical research and treatment methodologies. As he continues to explore the applications of his innovations, the scientific community looks forward to the potential breakthroughs that may arise from his work. His dedication to advancing healthcare underscores the importance of inventors in transforming ideas into tangible solutions for society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…